Technical Analysis for ELVN - Enliven Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Lower Bollinger Band Walk | Weakness | -2.86% | |
Lower Bollinger Band Touch | Weakness | -2.86% | |
Oversold Stochastic | Weakness | -2.86% | |
NR7 | Range Contraction | 2.13% | |
Lower Bollinger Band Walk | Weakness | 2.13% | |
Inside Day | Range Contraction | 2.13% | |
Lower Bollinger Band Touch | Weakness | 2.13% |
Alert | Time |
---|---|
Down 3% | about 18 hours ago |
60 Minute Opening Range Breakdown | about 21 hours ago |
10 DMA Resistance | about 21 hours ago |
Down 2 % | about 21 hours ago |
Down 1% | about 22 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Protein Kinase Inhibitor Tyrosine Kinase Receptors Her2 Chronic Myeloid Leukemia
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Protein Kinase Inhibitor Tyrosine Kinase Receptors Her2 Chronic Myeloid Leukemia
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 30.03 |
52 Week Low | 9.84 |
Average Volume | 281,575 |
200-Day Moving Average | 22.02 |
50-Day Moving Average | 26.42 |
20-Day Moving Average | 27.42 |
10-Day Moving Average | 26.44 |
Average True Range | 1.40 |
RSI (14) | 41.18 |
ADX | 25.16 |
+DI | 18.70 |
-DI | 24.49 |
Chandelier Exit (Long, 3 ATRs) | 25.59 |
Chandelier Exit (Short, 3 ATRs) | 27.89 |
Upper Bollinger Bands | 30.52 |
Lower Bollinger Band | 24.32 |
Percent B (%b) | 0.18 |
BandWidth | 22.59 |
MACD Line | -0.47 |
MACD Signal Line | -0.04 |
MACD Histogram | -0.4267 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 27.68 | ||||
Resistance 3 (R3) | 27.78 | 27.13 | 27.31 | ||
Resistance 2 (R2) | 27.13 | 26.56 | 27.08 | 27.18 | |
Resistance 1 (R1) | 26.28 | 26.20 | 25.96 | 26.18 | 27.05 |
Pivot Point | 25.63 | 25.63 | 25.47 | 25.58 | 25.63 |
Support 1 (S1) | 24.78 | 25.06 | 24.46 | 24.68 | 23.81 |
Support 2 (S2) | 24.13 | 24.70 | 24.08 | 23.68 | |
Support 3 (S3) | 23.28 | 24.13 | 23.56 | ||
Support 4 (S4) | 23.18 |